Vermont Xarelto Lawsuit Plaintiff Claims Anticoagulant Drug Caused Father’s Death

March 02, 2016 – – BloodThinnerHelp.com reports on another lawsuit which has been filed against Xarelto manufacturers Bayer AG and Janssen (a division of Johnson & Johnson corporation). The suit was initially filed in Vermont under case number 2:14-cv-00159-CR in the state’s federal court. It was filed by a young woman on behalf of her deceased father after he passed away due to uncontrollable bleeding. Her complaint, which has now been transferred to join other similar cases in multidistrict litigation number 2592, claims that the anticoagulant drug Xarelto caused the father’s sudden, uncontrollable bleeding episode, as well as his subsequent death.

In case details, the daughter explains that her father was prescribed Xarelto by his doctor as a treatment for his atrial fibrillation condition. Atrial fibrillation is a common heart condition which can cause the heart to beat more rapidly than what is considered normal. The condition puts patients at increased risk for strokes, so many of those with atrial fibrillation take blood thinning medications preventatively.

After taking the medication for just a short time, the father was reportedly injured and hospitalized. At the hospital, it was noted that he had suffered from a parenchymal hemorrhage (or brain bleed) and that physicians were unable to clot and stop the bleed. Because the man had active Xarelto in his system at the time, stopping the bleed proved to be too difficult, and after 6 full days of substantial blood loss, the man passed away.

At the time of the man’s death, Xarelto was given to patients without any available antidote provided by the manufacturer. This means that when patients using the drug became injured and bled, it was incredibly difficult to stop those bleeds, and they could easily become fatal. Traditional blood thinners were released to market with a corresponding antidote immediately, so patients taking these drugs who were injured and bleeding could be treated with that antidote (vitamin K), allowing their blood to clot and potentially saving their life.

Xarelto lawsuits filed from across the nation continue to increase in number, and currently amount to around 3,300. Over 2,800 of these filings have been consolidated to form multidistrict litigation number 2592, while the other 550 of more have become part of a mass tort group in Philadelphia, Pennsylvania.

As the plaintiffs involved await further litigation progress, many expect that other lawsuits will continue to be filed against the drug. Attorney Joseph Osborne is currently working to help ensure that everyone who used Xarelto and who suffered from health problems that they associate with their use of the drug will be given the important opportunity of evaluating their legal rights in full. These patients may be entitled to legal action and substantial compensation. At this time, Attorney Osborne is offering complimentary consultations for affected parties.

To request more information on Xarelto bleeding lawsuits, or to ask questions, please contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008478